Manuel Alvarez Amieva

Manuel Alvarez Amieva is a skilled professional currently serving as a Master Thesis Student in Cell Therapy R&D at Novo Nordisk since June 2022, following prior experience as an Intern in Cell Therapy Discovery. In addition, Manuel is a Student Assistant on the Surveillance Team at AGC Biologics since March 2022. Earlier experience includes a role as a Student Researcher in Clinical Microbiology at Hospital Universitario Central de Asturias, focusing on antibiotic susceptibility of C. trachomatis strains, and as a Quality Control Assistant at AGAR DE ASTURIAS SA. Manuel holds a Master’s degree in Pharmaceutical Design and Engineering from the Technical University of Denmark and a Bachelor of Science in Biology from Universidad de Oviedo.